Table 1. Anti-Respiratory Syncytial Virus Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Anti-Respiratory Syncytial Virus Drugs Market Restraints

Table 3. Anti-Respiratory Syncytial Virus Drugs Market Trends

Table 4. Anti-Respiratory Syncytial Virus Drugs Industry Policy

Table 5. Global Anti-Respiratory Syncytial Virus Drugs Revenue by Company, 2018-2023, US$ million

Table 6. Global Anti-Respiratory Syncytial Virus Drugs Revenue Market Share by Company, 2018-2023

Table 7. Global Anti-Respiratory Syncytial Virus Drugs Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share by Company, 2018-2023

Table 9. Global Anti-Respiratory Syncytial Virus Drugs Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Anti-Respiratory Syncytial Virus Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Anti-Respiratory Syncytial Virus Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Anti-Respiratory Syncytial Virus Drugs Manufacturers Product Type

Table 13. China Anti-Respiratory Syncytial Virus Drugs Revenue by Company, 2018-2023, US$ million

Table 14. China Anti-Respiratory Syncytial Virus Drugs Revenue Market Share by Company, 2018-2023

Table 15. China Anti-Respiratory Syncytial Virus Drugs Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Anti-Respiratory Syncytial Virus Drugs Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Anti-Respiratory Syncytial Virus Drugs Import & Export Trends

Table 19. Main Sources of China Anti-Respiratory Syncytial Virus Drugs Import

Table 20. Export Destination of China Anti-Respiratory Syncytial Virus Drugs

Table 21. Global Headquarters and Manufacturing Base of Anti-Respiratory Syncytial Virus Drugs Manufacturers

Table 22. Global Major Manufacturers, Anti-Respiratory Syncytial Virus Drugs Capacity Expansion and Future Plans

Table 23. Global Anti-Respiratory Syncytial Virus Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Anti-Respiratory Syncytial Virus Drugs Production by Region, 2018-2023, (K Units)

Table 25. Global Anti-Respiratory Syncytial Virus Drugs Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Anti-Respiratory Syncytial Virus Drugs Upstream (Raw Materials)

Table 27. Global Anti-Respiratory Syncytial Virus Drugs Typical Customers

Table 28. Anti-Respiratory Syncytial Virus Drugs Typical Distributors

Table 29. By Type, Global Anti-Respiratory Syncytial Virus Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Anti-Respiratory Syncytial Virus Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Anti-Respiratory Syncytial Virus Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Anti-Respiratory Syncytial Virus Drugs Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Anti-Respiratory Syncytial Virus Drugs Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Anti-Respiratory Syncytial Virus Drugs Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2018-2029

Table 37. By Country, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2018-2029

Table 39. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 40. AstraZeneca Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 41. AstraZeneca Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. AstraZeneca Company Profile and Main Business

Table 43. AstraZeneca Recent Developments

Table 44. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 45. Sanofi Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 46. Sanofi Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Sanofi Company Profile and Main Business

Table 48. Sanofi Recent Developments

Table 49. Janssen Pharmaceutica Company Information, Head Office, Market Area and Industry Position

Table 50. Janssen Pharmaceutica Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 51. Janssen Pharmaceutica Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Janssen Pharmaceutica Company Profile and Main Business

Table 53. Janssen Pharmaceutica Recent Developments

Table 54. Merck Company Information, Head Office, Market Area and Industry Position

Table 55. Merck Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 56. Merck Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Merck Company Profile and Main Business

Table 58. Merck Recent Developments

Table 59. Enanta Pharma Company Information, Head Office, Market Area and Industry Position

Table 60. Enanta Pharma Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 61. Enanta Pharma Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Enanta Pharma Company Profile and Main Business

Table 63. Enanta Pharma Recent Developments

Table 64. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 65. Pfizer Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 66. Pfizer Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Pfizer Company Profile and Main Business

Table 68. Pfizer Recent Developments

Table 69. GSK Company Information, Head Office, Market Area and Industry Position

Table 70. GSK Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 71. GSK Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. GSK Company Profile and Main Business

Table 73. GSK Recent Developments

Table 74. Shanghai Ark Biopharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 75. Shanghai Ark Biopharmaceutical Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 76. Shanghai Ark Biopharmaceutical Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Shanghai Ark Biopharmaceutical Company Profile and Main Business

Table 78. Shanghai Ark Biopharmaceutical Recent Developments

Table 79. Walvax Biotechnology Company Information, Head Office, Market Area and Industry Position

Table 80. Walvax Biotechnology Anti-Respiratory Syncytial Virus Drugs Models, Specifications and Application

Table 81. Walvax Biotechnology Anti-Respiratory Syncytial Virus Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Walvax Biotechnology Company Profile and Main Business

Table 83. Walvax Biotechnology Recent Developments

List of Figure

Figure 1. Anti-Respiratory Syncytial Virus Drugs Picture

Figure 2. By Revenue, Global Anti-Respiratory Syncytial Virus Drugs Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Anti-Respiratory Syncytial Virus Drugs Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Anti-Respiratory Syncytial Virus Drugs Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Anti-Respiratory Syncytial Virus Drugs Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Anti-Respiratory Syncytial Virus Drugs Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Anti-Respiratory Syncytial Virus Drugs Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Anti-Respiratory Syncytial Virus Drugs Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Anti-Respiratory Syncytial Virus Drugs Share of Global Market, 2018-2029

Figure 10. Global Anti-Respiratory Syncytial Virus Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Anti-Respiratory Syncytial Virus Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Anti-Respiratory Syncytial Virus Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Anti-Respiratory Syncytial Virus Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Anti-Respiratory Syncytial Virus Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Anti-Respiratory Syncytial Virus Drugs Domestic VS Export, 2022

Figure 16. Global Anti-Respiratory Syncytial Virus Drugs Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Anti-Respiratory Syncytial Virus Drugs Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Anti-Respiratory Syncytial Virus Drugs Production Market Share & Forecast by Region, 2018-2029

Figure 19. Anti-Respiratory Syncytial Virus Drugs Industry Chain

Figure 20. Anti-Respiratory Syncytial Virus Drugs Procurement Model

Figure 21. Anti-Respiratory Syncytial Virus Drugs Sales Model

Figure 22. Anti-Respiratory Syncytial Virus Drugs Sales Channels, Direct Sales and Distribution

Figure 23. Child Drug

Figure 24. Aldult Drug

Figure 25. By Type, Global Anti-Respiratory Syncytial Virus Drugs Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2018-2029

Figure 27. By Type, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Anti-Respiratory Syncytial Virus Drugs Price, 2018-2029, (US$/Unit)

Figure 30. Hospitals

Figure 31. Drugstores

Figure 32. Others

Figure 33. By Application, Global Anti-Respiratory Syncytial Virus Drugs Revenue, 2018-2029, US$ Million

Figure 34. By Application, Global Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2018-2029

Figure 35. By Application, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 36. By Application, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2018-2029

Figure 37. By Application, Global Anti-Respiratory Syncytial Virus Drugs Price, 2018-2029, (US$/Unit)

Figure 38. By Region, Global Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2018-2029

Figure 39. By Region, Global Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2018-2029

Figure 40. North America Anti-Respiratory Syncytial Virus Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 41. By Country, North America Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2022

Figure 42. Europe Anti-Respiratory Syncytial Virus Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, Europe Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2022

Figure 44. Asia Pacific Anti-Respiratory Syncytial Virus Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country/Region, Asia Pacific Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2022

Figure 46. South America Anti-Respiratory Syncytial Virus Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country, South America Anti-Respiratory Syncytial Virus Drugs Revenue Market Share, 2022

Figure 48. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. U.S. Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 50. By Company, U.S. Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 51. By Type, U.S. Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 53. Europe Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 54. By Company, Europe Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 55. By Type, Europe Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, Europe Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 57. China Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 58. By Company, China Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 59. By Type, China Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, China Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 61. Japan Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 62. By Company, Japan Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 63. By Type, Japan Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, Japan Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 65. South Korea Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 66. By Company, South Korea Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 67. By Type, South Korea Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, South Korea Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 69. Southeast Asia Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 70. By Company, Southeast Asia Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 71. By Type, Southeast Asia Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, Southeast Asia Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 73. India Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 74. By Company, India Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 75. By Type, India Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, India Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 77. Middle East & Asia Anti-Respiratory Syncytial Virus Drugs Sales Volume, 2018-2029, (K Units)

Figure 78. By Company, Middle East & Asia Anti-Respiratory Syncytial Virus Drugs Market Share, 2022

Figure 79. By Type, Middle East & Asia Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, Middle East & Asia Anti-Respiratory Syncytial Virus Drugs Sales Volume Market Share, 2022 VS 2029

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches